Xarelto Defective Drug Lawsuit

Xarelto is an anticoagulant blood thinner, it prevents hazardous blood clots from forming that could block the flow of blood to vital organs. It was FDA approved in 2011. Xarelto, also known as Rivaroxaban, is manufactured by Bayer and is marketed by Janssen Pharmaceutica, a subsidiary of Johnson and Johnson. Xarelto is a newer alternative […]

Ranitidine Cancer Lawsuit

Zantac (Ranitidine Linked to Cancer) The U.S Food and Drug Administration requested on April 1, 2020 that all manufacturers withdraw all ZANTAC and Generic ZANTAC OTC RANITIDINE drugs from the market immediately. The FDA determined that N-nitrosodimethylanmie (NDMA) levels in some RANITIDINE medications “increase significantly when stored at higher than room temperatures, including temperatures that […]